These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 21312324)

  • 1. Treatment of primary CNS lymphoma with high-dose methotrexate in immunocompetent patients.
    Cohen IJ
    Pediatr Blood Cancer; 2011 Jul; 56(7):1151. PubMed ID: 21312324
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of primary CNS lymphoma with high-dose methotrexate in immunocompetent pediatric patients.
    Shah AC; Kelly DR; Nabors LB; Oakes WJ; Hilliard LM; Reddy AT
    Pediatr Blood Cancer; 2010 Dec; 55(6):1227-30. PubMed ID: 20882580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical utility and pharmacology of high-dose methotrexate in the treatment of primary CNS lymphoma.
    Green MR; Chowdhary S; Lombardi KM; Chalmers LM; Chamberlain M
    Expert Rev Neurother; 2006 May; 6(5):635-52. PubMed ID: 16734512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [II. Primary treatment of CNS lymphoma with high-dose MTX].
    Iwadate Y
    Gan To Kagaku Ryoho; 2012 Jun; 39(6):892-7. PubMed ID: 22880222
    [No Abstract]   [Full Text] [Related]  

  • 5. Ogilvie's syndrome during chemotherapy with high-dose methotrexate for primary CNS lymphoma.
    Xie H; Peereboom DM
    J Clin Oncol; 2012 Jul; 30(21):e192-4. PubMed ID: 22711852
    [No Abstract]   [Full Text] [Related]  

  • 6. Primary central nervous system lymphoma: Phase I evaluation of infusional bromodeoxyuridine with whole brain accelerated fractionation radiation therapy after chemotherapy.
    Dabaja BS; McLaughlin P; Ha CS; Pro B; Meyers CA; Seabrooke LF; Wilder RB; Kyritsis AP; Preti HA; Yung WK; Levin V; Cabanillas F; Cox JD
    Cancer; 2003 Sep; 98(5):1021-8. PubMed ID: 12942571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How important is whole brain radiotherapy for treatment of primary CNS lymphoma?
    Cabanillas F
    Lancet Oncol; 2010 Nov; 11(11):1011-2. PubMed ID: 20970379
    [No Abstract]   [Full Text] [Related]  

  • 8. Primary central nervous system (CNS) lymphoma in immunocompetent patients.
    Plasswilm L; Herrlinger U; Korfel A; Weller M; Küker W; Kanz L; Thiel E; Bamberg M
    Ann Hematol; 2002 Aug; 81(8):415-23. PubMed ID: 12223997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NOA-03 trial of high-dose methotrexate in primary central nervous system lymphoma: final report.
    Herrlinger U; Küker W; Uhl M; Blaicher HP; Karnath HO; Kanz L; Bamberg M; Weller M;
    Ann Neurol; 2005 Jun; 57(6):843-7. PubMed ID: 15929034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic anaphylactic reaction following intrathecal administration of methotrexate in adult patient with primary central nervous system lymphoma.
    Elkiran ET; Altundag K; Aksoy S; Onal IK; Tekuzman G
    Am J Hematol; 2004 Apr; 75(4):265. PubMed ID: 15054831
    [No Abstract]   [Full Text] [Related]  

  • 11. Non-Hodgkin's lymphoma and the CNS: prophylaxis and therapy in immunocompetent and HIV-positive individuals.
    Mazhar D; Stebbing J; Bower M
    Expert Rev Anticancer Ther; 2006 Mar; 6(3):335-41. PubMed ID: 16503851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preliminary results of combined chemotherapy and radiotherapy for non-AIDS primary central nervous system lymphoma. Trans-Tasman Radiation Oncology Group (TROG).
    O'Brien PC; Roos DE; Liew KH; Trotter GE; Barton MB; Walker QJ; Poulsen MG; Olver IN
    Med J Aust; 1996 Oct; 165(8):424-7. PubMed ID: 8913243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is intrathecal methotrexate necessary in the treatment of primary CNS lymphoma?
    Khan RB; Shi W; Thaler HT; DeAngelis LM; Abrey LE
    J Neurooncol; 2002 Jun; 58(2):175-8. PubMed ID: 12164690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Primary central nervous system lymphoma: diagnosis, management and current topics].
    Arita N
    No To Shinkei; 2004 Mar; 56(3):195-203. PubMed ID: 15112444
    [No Abstract]   [Full Text] [Related]  

  • 15. High-dose chemotherapy and autologous stem-cell transplantation without consolidating radiotherapy as first-line treatment for primary lymphoma of the central nervous system.
    Illerhaus G; Müller F; Feuerhake F; Schäfer AO; Ostertag C; Finke J
    Haematologica; 2008 Jan; 93(1):147-8. PubMed ID: 18166803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary central nervous system lymphomas: salvage treatment after failure to high-dose methotrexate.
    Reni M; Mazza E; Foppoli M; Ferreri AJ
    Cancer Lett; 2007 Dec; 258(2):165-70. PubMed ID: 17993246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modified ProMACE-MOPP hybrid regimen with moderate-dose methotrexate for patients with primary CNS lymphoma.
    Yamanaka R; Morii K; Shinbo Y; Takeuchi S; Tamura T; Hondoh H; Takahashi H; Onda K; Takahashi H; Tanaka R
    Ann Hematol; 2005 Jul; 84(7):447-55. PubMed ID: 15747120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal dysfunction during and after high-dose methotrexate.
    Green MR; Chamberlain MC
    Cancer Chemother Pharmacol; 2009 Mar; 63(4):599-604. PubMed ID: 18504579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of relapsed central nervous system lymphoma with high-dose methotrexate.
    Plotkin SR; Betensky RA; Hochberg FH; Grossman SA; Lesser GJ; Nabors LB; Chon B; Batchelor TT
    Clin Cancer Res; 2004 Sep; 10(17):5643-6. PubMed ID: 15355887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary central nervous system lymphoma: monocenter, long-term, intent-to-treat analysis.
    Kiewe P; Fischer L; Martus P; Thiel E; Korfel A
    Cancer; 2008 Apr; 112(8):1812-20. PubMed ID: 18318432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.